Darius Paduch, M.D PHD

Caitlin Gribbin, MD, is an Assistant Professor of Medicine within the Division of Hematology and Oncology at Weill Cornell Medical Center. After earning her B.A. from Cornell University, Dr. Gribbin received her Medical Degree as well as Masters in Science from Weill Cornell Medical College. She completed her Internship and Residency as well as subsequent Fellowship training in Hematology and Oncology within the Medical Research Track at Weill Cornell Medicine/NewYork-Presbyterian Hospital. As a faculty member at Weill Cornell, Dr. Gribbin specializes in treating patients with lymphoma using cellular therapies, including chimeric antigen receptor (CAR) T cell therapy. She is simultaneously focused on leading clinical and translational research studies aimed at improving lymphoma treatments by bringing novel scientific discoveries to patients. Dr. Gribbin has co-authored numerous publications and presentations at national and international meetings and has received several research grants, including the American Society of Clinical Oncology (ASCO) Young Investigator Award, the Lymphoma Research Foundation (LRF) Scientific Research Mentoring Program Award, and the Burroughs Wellcome Fund Award.

Dr. Su Yuan grew up in Toronto, Canada where she completed her undergraduate degree in Human Biology from the University of Toronto. She completed her medical degree at the University of Calgary, then her Internal Medicine and Cardiology training at the University of Saskatchewan. She completed specialized training in adult echocardiography at the University of Alberta Mazankowski Heart Institute in Edmonton, and in adult congenital heart disease (ACHD) at the University of Toronto, Toronto General Hospital. She also has a Masters degree in Epidemiology and Biostatistics from the University of Western Ontario.Dr. Yuan joined the full-time faculty at Weill Cornell Medical College and NewYork-Presbyterian Hospital as a specialist in Adult Congenital Heart Disease and Echocardiography. Her cardiologist practice includes patients with both acquired and congenital heart disease.